Cannabis Use Disorder in Women — A Modern Picture
Cannabis use disorder is a recognized clinical condition, increasingly common as high-potency cannabis products have become widely…
Read articleLSD is not physically addictive in the way alcohol, opioids, or stimulants are — no withdrawal syndrome, minimal tolerance buildup. The real risks are different: psychological. Bad trips, persistent perceptual changes (HPPD), psychosis triggering in vulnerable people, panic during the experience, and use as avoidance of underlying mental health issues. For women with trauma, anxiety, or any psychotic-spectrum risk, LSD carries elevated psychological risks. Frequent or compulsive use — even without classical addiction — can warrant clinical attention.

“ATR has been a wonderful organization to work with. I've partnered with them on many occasions on behalf of my own clients. They're trustworthy, ethical and provide excellent clinical care to the women they serve.”
LSD is one of the most-discussed and most-misunderstood substances in addiction conversations. It doesn't produce classical addiction. It doesn't cause overdose deaths in typical doses. The cultural conversation around it has shifted dramatically with the rise of psychedelic-assisted therapy research. And it also produces real harms — different from substances like alcohol or opioids, but real. This guide is honest about both sides.
LSD (lysergic acid diethylamide) is a synthetic hallucinogen first synthesized in 1938. It produces profound changes in perception, mood, and thought processes by acting primarily on serotonin receptors, particularly the 5-HT2A receptor. Effects typically last 8-12 hours, with the most intense effects in hours 2-6.
Common subjective effects:
This doesn't mean LSD is harmless — it means the risk profile is different. The substance doesn't grip the brain the way opioids or stimulants do. The harms come elsewhere.
Acute negative experiences during use — overwhelming fear, paranoia, derealization, traumatic-feeling experiences. Most last hours; some have lasting psychological effects. Risk factors: pre-existing anxiety or mental health concerns, unsafe setting, unknown dose, mixing with other substances, recent trauma, current life crisis.
Persistent visual or perceptual changes lasting days, weeks, months, or rarely years after use. Common features: visual snow, trailing or motion of objects, halos around lights, persistent geometric patterns in peripheral vision. HPPD can range from mildly noticeable to significantly distressing. No clear way to predict who develops it; can occur after a single use or after many.
In people with predisposition to psychotic disorders (schizophrenia, schizoaffective disorder, bipolar I disorder), LSD can trigger or accelerate the onset of psychotic episodes. Family history of psychotic disorders is a significant risk factor. Some episodes resolve; some persist into a lasting condition that may have developed regardless but was accelerated by use.
For people with existing anxiety disorders or trauma histories, LSD can intensify or trigger symptoms. Trauma-related material can surface during trips in ways that are difficult to process without clinical support. Some women describe traumatic experiences during use that produce their own PTSD-like symptoms afterward.
Impaired judgment during use can produce dangerous decisions — falls, accidents, unsafe interactions with others, exposure to harm. The 8-12 hour duration extends the risk window substantially compared to shorter-acting substances.
"LSD" sold on the street may not be LSD. Common substitutes include NBOMe compounds, which can be significantly more dangerous than LSD itself — causing seizures, cardiovascular events, and deaths. Without a controlled supply, what's actually being consumed is uncertain.
Even without classical addiction, LSD use can warrant clinical attention when:

The cultural conversation around LSD has shifted with research into psychedelic-assisted therapy. Worth being clear about what that research does and doesn't say:
Anchored Tides doesn't currently provide psychedelic-assisted therapy. Women interested in that path should pursue it through established clinical trial programs with appropriate medical screening and integration support.
Treatment differs from substance use disorders that involve physical dependence:
If LSD use has become more frequent than intended, started affecting mental health, or produced lasting effects you're worried about — a confidential conversation can help you sort out what's happening and what kind of support might help.
Call (866) 329-6639 or Verify Your Insurance — confidential, no obligation.
Not in the classical sense — no physical withdrawal, rapid tolerance buildup that limits frequency, minimal cravings. But use can still become problematic in other ways: compulsive patterns, mental health worsening, HPPD, persistent psychological effects from bad trips, or use as avoidance of underlying issues. Problematic use without classical addiction is still worth clinical attention.
Hallucinogen Persisting Perception Disorder — persistent visual or perceptual changes lasting days to years after hallucinogen use. Common symptoms include visual snow, trailing or motion of objects, halos, and persistent geometric patterns in peripheral vision. Can be mild and noticeable, or significantly distressing. Treatment is symptomatic — sometimes medications help, often time and reduced anxiety about the symptoms themselves.
LSD doesn't cause schizophrenia in people without underlying predisposition. In people with predisposition (family history, prodromal symptoms), it can trigger or accelerate onset of psychotic episodes. Family history of schizophrenia, bipolar I disorder, or schizoaffective disorder is a meaningful contraindication. The risk is real but applies primarily to people with vulnerability — not the general population.
Depends on what's happening afterward. A bad trip that you process and move past doesn't necessarily warrant clinical concern. A bad trip followed by lasting anxiety, intrusive memories, persistent perceptual changes, or significant distress weeks later does warrant clinical attention. Trauma-focused therapy (including EMDR) can address bad trip aftermath effectively.
The evidence base is still developing. Some research suggests potential benefits; some research raises concerns. Microdosing isn't truly studied at the rigor of clinical trial doses, and the long-term effects of regular sub-perceptual use aren't well-understood. Women considering microdosing should discuss it with a clinician familiar with both psychedelic research and their personal medical history.
Evidence & accountability
This page was reviewed by Zoe Tambling, LMFT on . The references below informed the specific topics noted with each citation.
Ready to take the next step?
Call (866) 329-6639 or verify your insurance — confidential, no obligation. Women-only environment, Joint Commission accredited.